Medical Grade Silicone Market Size was valued at USD 0.32 billion in 2023. The medical grade silicone industry is projected to grow from USD 0.34 Billion in 2024 to USD 0.50 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.87% during the forecast period (2024 - 2032).An increasing number of cardiovascular diseases Technological advances and improved healthcare facility quality the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The high rise in implanted devices is driving the market CAGR for medical grade silicone. Medical implants are man-made items that are used to replace biological parts that have been damaged or are missing. It is applied within or on top of the bodily layer. Drug distribution, body monitoring, and organ and tissue support are all aided by implants. These are employed in medical applications such as dentistry, orthopedics, breast implants, and cardiovascular devices. The medical implant industry is being driven by an increase in chronic diseases such as osteoarthritis, cardiovascular disease, neuropathic diseases, and congenital disorders. The adoption of coatings in these applications will raise implant demand in various segments of the medical business.
In addition, increased biocompatibility and hydrophobicity of medical grade silicone products, along with a wide range of options for consumers, have changed the market's makeup. The market is growing due to the use of medical grade silicone in the production of medical devices such as surgical instruments, defibrillators, heart pumps, disposable devices, and many more. Demand for medical components is rising due to the prevalence of chronic diseases like cardiovascular and orthopedic. The market may expand as a result of improved medical grade features such lighter weight medical devices and qualities that make them disposable.
Furthermore, growing healthcare expenses and higher healthcare infrastructure investments in emerging economies are likely to fuel market revenue growth.
For instance, the Indian government has launched several programs to promote the use of medical equipment and devices in the country, such as the Make in India program and the National Health Policy, which are expected to increase demand for medical grade silicone rubber products in the area. Furthermore, the rising demand for medical grade silicone rubber in the healthcare industry is likely to drive market revenue growth.
The medical grade silicone market segmentation, based on product includes elastomers, gels, medical adhesives, medical coatings and others. The elastomers category dominated the medical silicone market, accounting for 46.4% of volume share in 2022. The polymers' notable features, such as hypoallergenicity, non-reactivity with most chemicals, high tear strength, outstanding thermal conductivity, and great fire resistance, drive demand. LSR and HCR elastomers are utilized to make medical tubing, equipment, and components. However, the need for liquid silicone rubber in moulding applications is expected to expand significantly as a result of low viscosity assisting the creation of intricate and sophisticated moulds over HCR, hence driving demand in the coming years.
Figure1: Medical Grade Silicone Market, by Product, 2022 & 2032 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The medical grade silicone market segmentation, based on application, includes medical devices, medical tapes, orthopedics, prosthetics and contact lenses. The medical devices and components segment is expected to account for largest revenue share during the forecast period due to its distinctive qualities, including biocompatibility, chemical resistance, and high-temperature stability. Medical grade silicone rubber is utilized extensively in medical equipment and parts in the healthcare sector for a variety of tasks including diagnostic, therapeutic, and surgical treatments. Moreover, medical grade silicone rubber-made components and devices are extremely strong, flexible, and simple to work with, making them perfect for intricate medical applications.
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America is predicted to account for the largest revenue share throughout the projection period due to its established healthcare infrastructure, rising healthcare spending, and expanding adoption of cutting-edge medical equipment. Furthermore, the region's growing senior population, higher prevalence of chronic ailments, and rising desire for less invasive treatments are driving up demand for medical grade silicon rubber.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: MEDICAL GRADE SILICONE MARKET SHARE BY REGION 2022 (%) 
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe’s medical grade silicone market accounts for the second-largest market share due to well-established healthcare infrastructure and rising acceptance of cutting-edge medical equipment. Further, the German medical grade silicone market held the largest market share, and the UK medical grade silicone market was the fastest-growing market in the European region
The Asia-Pacific Medical Grade Silicone Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to growing private sector involvement in the production and distribution of pharmaceuticals, medical equipment, and supplies to enhance healthcare infrastructure and provide high-quality care. Moreover, China’s medical grade silicone market held the largest market share, and the Indian medical grade silicone market was the fastest-growing market in the Asia-Pacific region.
Leading market players are investing heavily in R&D in order to expand their product lines, which will help the medical grade silicone market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, medical grade silicone industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the medical grade silicone industry to benefit clients and increase the market sector. In recent years, the medical grade silicone industry has offered some of the most significant advantages to medicine. Major players in the medical grade silicone market, including 3M (U.S.), Saint-Gobain Performance Plastics (France), Koninklijke DSM N.V. (Netherlands), Momentive (U.S.), Zodiac Coating SAS (France), Trelleborg AB (Sweden) and others, are attempting to increase market demand by investing in R&D operations.
Momentive Inc. is a chemical firm based in the United States. Silicones and quartz are among its goods. The company's headquarters are in Waterford, New York. The corporation employs 9,200 people in over 50 locations spanning North America, Europe, Asia, and South America.[10] It made $6.5 billion in sales in 2019. Forbes ranked the corporation as the 64th largest private company in the United States in 2019. Momentive is the fourth-largest company in New York State's Capital Region, employing approximately 1,000 people at its Waterford plant. The direct technique was first developed by GE research chemist Eugene G. Rochow, who founded the company. Momentive Performance Materials was founded after GE Advanced Materials was sold to Apollo Management in 2006. In September 2020, Momentive Performance Materials Inc. has announced the creation of a new medical grade silicone rubber technology that can survive extreme sterilizing conditions while retaining its physical and mechanical qualities. The new technology is intended to improve the performance and dependability of medical devices and products.
Shin-Etsu Chemical Co., Ltd. is Japan's largest chemical corporation, ranking ninth in the Forbes 2000 for the chemical sector. Shin-Etsu dominates the polyvinyl chloride, semiconductor silicon, and photomask substrate markets. In 2011, 2012, 2013, and 2014, the company was designated one of Thomson Reuters' Top 100 Innovators. The name "Shin-Etsu" is derived from the Shin'etsu Region, where the firm founded the first chemical plant as Shin-Etsu Nitrogen Fertilizer in 1926, while the corporation is now based in Tokyo and has manufacturing facilities in 14 countries across the world. In July 2020, Shin-Etsu Chemical Co. Ltd. announced the increase of its medical grade silicone rubber production capacity in Japan to fulfill rising healthcare industry demand. The development sought to meet the region's growing need for silicone rubber goods for medical purposes.
3M (U.S.)
Saint-Gobain Performance Plastics (France)
Koninklijke DSM N.V. (Netherlands)
Momentive (U.S.)
Zodiac Coating SAS (France)
Trelleborg AB (Sweden)
Shin-Etsu Chemical Co. Ltd (Japan)
Nusil Technology LLC (U.S.)
Henkel AG & Co. KGaA (Germany)
Polymer Science Inc (U.S.)
Applied Silicone Corporation (US.)
Primasil Silicones Ltd. (U.K)
In February 2020, Elkem Silicone recently announced the purchase of Polysil, a silicone elastomer and resins material manufacturer with a focus on silicone products for the electronics and medical markets as well as silicones for infant care and food-grade applications. Elkem benefits from Polysil's products and market leadership in the food, baby care, electronics, and medical sectors. This helps Elkem expand in the Chinese market for medical grade silicone.
In March 2022, Minnesota Rubber and Plastics (MRP), a provider of elastomer and thermoplastic solutions for the medical, water, and specialty industrial end markets, announced the acquisition of Primasil Silicones, a custom silicone rubber compounder, mixer, and manufacturer based in the United Kingdom. MP's existing offers, which include elastomer and thermoplastic solutions for the medical device, water, food and beverage, infrastructure, and other critical industries worldwide, will be supplemented by the acquisition of Primasil's expertise.
In January 2022, B9Creations, a developer of additive manufacturing solutions, has introduced the BoRes - Silicone elastomeric resin. This latest addition to its biocompatible 3D printing materials allows for tailored medical and consumer tech applications for comfortable skin contact items such as headphones, hearing aids, wristbands, wearable attachments, silicone components for medical devices, and more.
Medical Grade Silicone Market Product Outlook
Elastomers
Gels
Medical Adhesives
Medical Coatings
Others
Medical Grade Silicone Market Application Outlook
Medical Devices
Medical Tapes
Orthopedics
Prosthetics
Contact Lenses
Medical Grade Silicone Regional Outlook
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.32 billion |
| Market Size 2024 | USD 0.34 billion |
| Market Size 2032 | USD 0.50 billion |
| Compound Annual Growth Rate (CAGR) | 4.87% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, and Region |
| Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | 3M (U.S.), Saint-Gobain Performance Plastics (France), Koninklijke DSM N.V. (Netherlands), Momentive (U.S.), Zodiac Coating SAS (France), Trelleborg AB (Sweden), Shin-Etsu Chemical Co., Ltd (Japan), Nusil Technology LLC (U.S.). Henkel AG & Co. KGaA (German). Folymer Science, Inc. (U.S.), Applied Silicone Corporation (U.S.), Primasil Silicones Ltd. (U.K) |
| Key Market Opportunities | Growing use of medical devices. |
| Key Market Dynamics | Increased chronic diseases. |
Medical Grade Silicone Market Highlights:
Frequently Asked Questions (FAQ) :
North America would make the maximum impact on the medical-grade silicone market.
The medical grade silicone market size was valued at USD 0.32 Billion in 2023
The market is projected to grow at a CAGR of 4.87% during the forecast period, 2024-2032
North America had the largest share of the market
The key players in the market are 3M (U.S.), Saint-Gobain Performance Plastics (France), Koninklijke DSM N.V. (Netherlands), Momentive (U.S.), Zodiac Coating SAS (France), Trelleborg AB (Sweden)
The elastomers medical grade silicone category dominated the market in 2023
The medical devices had the largest share of the market
Research Analyst Level I In her 3 years of experience in the market research field, she has handled critical cross-domain projects. she has an in-depth knowledge of market estimation & analysis, problem-solving, primary as well as secondary research, and team management.she holds an engineering degree and is an mba professional from a well-known university, capable of evaluating the market and competitive conditions. an exceptional strategist with excellent communication skills and a passion for delivering cutting-edge & practical insights for the market. proficient in multi-tasking, and can successfully deal with competing demands, while maintaining complete confidentiality. generated business through active client and project development, networking, and high-quality responses. her knowledge and skills have helped in making solid business decisions, securing funding from investors, and avoiding business failures.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
